Forecasting the Incidence of Testis Cancer in Europe from 2012-2035
Abstract
Forecasting the Incidence of Testis Cancer in Europe from 2012-2035
Ferlay J, Soerjomataram I, Dikshit R et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136(5): E359-86.
Magelssen H, Brydøy M, Fosså SD (2006). The effects of cancer and cancer treatments on male reproductive function. Nat Clin Pract Oncol, 3(6):312-22.
Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM (2010). GLOBOCAN 2008, cancer incidence and mortality worldwide. https://www.iarc.fr/en/media-centre/iarcnews/2010/globocan2008.php
Ross R, McCurtis J, Henderson B et al (1979). Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer, 39(3):284-9.
Osterlind A (1986). Diverging trends in inci-dence and mortality of testicular cancer in Denmark, 1943-1982. Br J Cancer, 53(4):501-05.
Power D, Brown R, Brock C et al (2001). Trends in testicular carcinoma in England and Wales, 1971–99. BJU Int, 87(4):361-5.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh J, Comber H, Forman D, Bray F(2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer, 49(6):1374-403.
Ferlay J SI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F(2013). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer. http://globocan.iarc.fr/Default.aspx
| Files | ||
| Issue | Vol 46 No 10 (2017) | |
| Section | Letter to the Editor | |
| Keywords | ||
| No keywords## | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
